Abstract
Purpose
This study systematically reviewed our team’s research on the mechanism and assessment of liver fibrosis in BA, summarized our experience, and discussed the future development direction.
Methods
In this study, Pubmed and Wanfang databases were searched to collect the literature published by our team on the mechanisms of liver fibrosis in BA and the assessment of liver fibrosis in BA, and the above research results were systematically reviewed.
Results
A total of 58 articles were retrieved. Among the included articles, 25 articles related to the mechanism of liver fibrosis in BA, and five articles evaluated liver fibrosis in BA. This article introduces the key pathways and molecules of liver fibrosis in BA and proposes a new grading system for liver fibrosis in BA.
Conclusions
The new BA liver fibrosis grading method is expected to assess children’s conditions, guide treatment, and improve prognosis more accurately. In addition, we believe that the TGF-β1 signaling pathway is the most important in the study of liver fibrosis in BA, and at the same time, the study of EMT occurrence in BA should also be deepened to resolve the controversy on this issue.
Similar content being viewed by others
Data availability
No datasets were generated or analyzed during the current study.
References
Sutton H, Karpen SJ, Kamath BM (2024) Pediatric cholestatic diseases: common and unique pathogenic mechanisms. Annu Rev Pathol 19:319–344. https://doi.org/10.1146/annurev-pathmechdis-031521-025623
Quelhas P, Cerski C, Dos Santos JL (2022) Update on etiology and pathogenesis of biliary atresia. Curr Pediatr Rev 19(1):48–67. https://doi.org/10.2174/1573396318666220510130259
Liu S, Yang Q, Ji Q, Wang Z, Sun R, Zhan J (2024) Effect of Kasai procedure on liver transplantation in children with biliary atresia: a systematic review and updated meta-analysis. Transl Pediatr 13(1):10–25. https://doi.org/10.21037/tp-23-504
Xu X, Wang X, Ding M et al (2023) Development and post-Kasai procedure prognostic relevance of histological features for biliary atresia. BMC Pediatr 23(1):589. https://doi.org/10.1186/s12887-023-04413-3
Wang Z, Chen Y, Peng C et al (2019) Five-year native liver survival analysis in biliary atresia from a single large Chinese center: the death/liver transplantation hazard change and the importance of rapid early clearance of jaundice. J Pediatr Surg 54(8):1680–1685. https://doi.org/10.1016/j.jpedsurg.2018.09.025
Song T, Zhan Ji, Gao W, Liu D, Zhang H (2015) Expression of CD14, CD34 and transforming growth factor-1 in liver biopsy of biliary atresia. Chin J Pediatr Surg 36(1):63–67. https://doi.org/10.3760/cma.j.issn.0253-3006.2015.01.015
Yu C, Xiong X, Zhan J, Hu Xi, Gao W (2019) Expression and clinical significance of MMP-7 in hepatic fibrosis of biliary atresia. Tianjin Med J 47(1):38–42. https://doi.org/10.11958/20181302
Wang H, Zhao J, Gou Q et al (2021) Expression of SOX9 in biliary atresia and its relationship with hepatic fibrosis. Chin J Pediatr Surg 42(6):512–518. https://doi.org/10.3760/cma.j.cn421158-20201119-00708
Chen Li, Zhan J, Zhao J et al (2022) The diagnostic value of glypican 3 in children with biliary atresia and its relationship with liver fibrosis. Tianjin Med J 50(1):15–19. https://doi.org/10.11958/20211114
Wang Q, Zheng Q, Zhang C et al (2022) Clinical significance of expression of leptin in patients with biliary atresia and hepatic fibrosis. Chin J Hepatobiliary Surg 28(4):275–279. https://doi.org/10.3760/cma.j.cn113884-20211119-00377
Zhang C, Zhao J, Zheng Q et al (2022) Clinical implications of M2BP and M2BPGi in hepatic fibrosis of children with biliary atresia. Chin J Pediatr Surg 43(3):214–220. https://doi.org/10.3760/cma.j.cn421158-20210110-00016
Liu Z, Zheng Q, Xu X et al (2023) Expression and clinical significance of CD163 in hepatic fibrosis with biliary atresia. Tianjin Med J 51(4):400–403. https://doi.org/10.11958/20221539
Wang X, Xu X, Li M et al (2023) Expression and clinical significance of CCL25/CCR9 in liver fibrosis of biliary atresia. Chin J Pediatr Surg 44(10):897–903. https://doi.org/10.3760/cma.j.cn421158-20230601-00266
Xu X, Wang X, Liu S et al (2023) Relationship between HDAC2 expression score and progression and prognosis of liver fibrosis in biliary atresia. Chin J Pediatr Surg 44(10):874–881. https://doi.org/10.3760/cma.j.cn421158-20230601-00265
Yang R, Zhang C, Chen L et al (2023) Mechanism of FN1 promoting hepatic stellate cell activation via PI3K/Akt signaling pathway in hepatic fibrosis of biliary atresia. Chin J Pediatr Surg 44(2):114–124. https://doi.org/10.3760/cma.j.cn421158-20211116-00563
Ding M, Gao T, Wei Y, Zhao L, Zhan J (2016) The study on mechanism of p-smad3 in hepatic fibrosis of biliary atresia. J Clin Ped Sur 1:29–33. https://doi.org/10.3969/j.issn.1671-6353.2016.01.009
Ding M, Zhan J, Zhao L, Zhao L, Zhang A (2016) The effects of TGF-β1 and Smad2 on liver fibrosis of biliary atresia. Tianjin Med J 44(7):810–813. https://doi.org/10.11958/20150242
Gao T, Zhan J, Ding M, Wei Y (2016) The expression and significance of integrinαvβ8, p38 and ERK1/2 in the liver of children with biliary atresia. Tianjin Med J. https://doi.org/10.11958/20160362
Gao T, Zhan J, Chen Y, Zhang A, Wei Y (2017) Effects of JNK2, TIMP-1 and collagen III on liver fibrosis in patients with biliary atresia. J Clin Ped Sur 16(2):127–132. https://doi.org/10.3969/j.issn.1671-6353.2017.02.006
Yan P, Zheng Y, Chen H et al (2018) Mechanism of plasminogen activator inhibitor-1 promoting liver fibrosis in biliary atresia. J Clin Ped Sur 17(10):790–794
Ge L, Gou Q, Zhao J et al (2021) The study on the mechanism of BMP-9 in liver fibrosis of biliary atresia. Tianjin Med J 49(10):1020–1025. https://doi.org/10.11958/20210765
Zhao J, Xu X, Gou Q et al (2022) TGF-β1-mediated leukocyte cell-derived chemotaxin 2 Is associated with liver fibrosis in biliary atresia. Front Pediatr 10:901888. https://doi.org/10.3389/fped.2022.901888
Zhang S, Chen Y, Gao T, Zhan J (2017) Effects of RhoA, Rac1 and Cdc42 on liver fibrosis in patients with biliary atresia. Chin J Pediatr Surg 38(11):816–821. https://doi.org/10.3760/cma.j.issn.0253-3006.2017.11.003
Gou Q, Zheng Q, Zhao J et al (2021) Expression and mechanism of Hedgehog signaling pathway in liver fibrosis of biliary atresia. Chin J Pediatr Surg 42(9):774–780. https://doi.org/10.3760/cma.j.cn421158-20210106-00008
Zheng Q, Gou Q, Zhao J et al (2022) Mechanism of epidermal growth factor in hepatic fibrosis of biliary atresia. Chin J Pediatr Surg 43(4):310–315. https://doi.org/10.3760/cma.j.cn421158-20210105-00014
Zheng Q, Li M, Chen L et al (2023) Potential therapeutic target of EGF on bile duct ligation model and biliary atresia children. Pediatr Res 94(4):1297–1307. https://doi.org/10.1038/s41390-023-02592-4
Wei Y, Ding M, Gao T, Hu X, Zhan J (2016) The expression of HIF-1αand VEGF in the patients with biliary atresia. J Clin Ped Sur 1:34–37. https://doi.org/10.3969/j.issn.1671-6353.2016.01.010
Zhao J, Dou R, Zheng Q et al (2020) Expression and clinical significance of LECT2 in biliary atresia hepatic fibrosis. Chin J Pediatr Surg 41(7):633–639. https://doi.org/10.3760/cma.j.cn421158-20200222-00110
Jia J, Zhan J, Yu C, Xiong X, Hu X (2019) Expression and significance of Notch-1, Jagged-1 and Hes-1 in liver fibrosis of children with biliary atresia. Chin J Pediatr Surg 40(5):399–403. https://doi.org/10.3760/cma.j.issn.0253-3006.2019.05.004
Abudureyimu A, Lin F, Wang H et al (2021) Activation of Notch signaling pathway collaborated with macrophages for promoting liver fibrosis in biliary atresia. J Clin Ped Sur 20(4):376–381. https://doi.org/10.12260/lcxewkzz.2021.04.014
Guan Z, Zhan J, Hu X, Luo X, Bao G, Liu Y (2012) The assessment and significance of liver fibrosis in children with biliary atresia. Chin J Pediatr Surg 33(11):815–819. https://doi.org/10.3760/cma.j.issn.0253-3006.2012.11.004
Ding M, Zhan J, Liu D, Zhang H, Wei Y, Gao T (2015) Grading of hepatic fibrosis in biliary atresia. Chin J Pediatr Surg 36(11):866–872. https://doi.org/10.3760/cma.j.issn.0253-3006.2015.11.016
Yu C, Zhan J, Gao W, Wang Z (2017) Clinicopathological analysis with different native liver survivals for biliary atresia after Kasai. J Clin Ped Sur 16(6):552–558. https://doi.org/10.3969/j.issn.1671-6353.2017.06.007
Xiong X, Zhan J, Yu C, Hu X, Zhao L (2018) Relationship between native liver survival and ductular reaction in biliary atresia. J Clin Ped Sur 17(11):814–820. https://doi.org/10.3969/j.issn.1671-6353.2018.11.004
Iordanskaia T, Hubal MJ, Koeck E, Rossi C, Schwarz K, Nadler EP (2013) Dysregulation of upstream and downstream transforming growth factor-β transcripts in livers of children with biliary atresia and fibrogenic gene signatures. J Pediatr Surg 48(10):2047–2053. https://doi.org/10.1016/j.jpedsurg.2013.03.047
Xu F, Liu C, Zhou D, Zhang L (2016) TGF-β/SMAD pathway and its regulation in hepatic fibrosis. J Histochem Cytochem 64(3):157–167. https://doi.org/10.1369/0022155415627681
Jiang Y, Wu C, Boye A et al (2015) MAPK inhibitors modulate Smad2/3/4 complex cyto-nuclear translocation in myofibroblasts via Imp7/8 mediation. Mol Cell Biochem 406(1–2):255–262. https://doi.org/10.1007/s11010-015-2443-x
Mu D, Cambier S, Fjellbirkeland L et al (2002) The integrin alpha(v)beta8 mediates epithelial homeostasis through MT1-MMP-dependent activation of TGF-beta1. J Cell Biol 157(3):493–507. https://doi.org/10.1083/jcb.200109100
Breitkopf-Heinlein K, Meyer C, König C et al (2017) BMP-9 interferes with liver regeneration and promotes liver fibrosis. Gut 66(5):939–954. https://doi.org/10.1136/gutjnl-2016-313314
Addante A, Roncero C, Almalé L et al (2018) Bone morphogenetic protein 9 as a key regulator of liver progenitor cells in DDC-induced cholestatic liver injury. Liver Int 38(9):1664–1675. https://doi.org/10.1111/liv.13879
Chen Y, Fan Y, Guo DY et al (2020) Study on the relationship between hepatic fibrosis and epithelial-mesenchymal transition in intrahepatic cells. Biomed Pharmacother 129:110413. https://doi.org/10.1016/j.biopha.2020.110413
Wang JY, Cheng H, Zhang HY et al (2019) Suppressing microRNA-29c promotes biliary atresia-related fibrosis by targeting DNMT3A and DNMT3B. Cell Mol Biol Lett 24:10. https://doi.org/10.1186/s11658-018-0134-9
Cui S, Leyva-Vega M, Tsai EA et al (2013) Evidence from human and zebrafish that GPC1 is a biliary atresia susceptibility gene. Gastroenterology 144(5):1107-1115.e3. https://doi.org/10.1053/j.gastro.2013.01.022
Tang V, Cofer ZC, Cui S, Sapp V, Loomes KM, Matthews RP (2016) Loss of a candidate biliary atresia susceptibility gene, add3a, causes biliary developmental defects in zebrafish. J Pediatr Gastroenterol Nutr 63(5):524–530. https://doi.org/10.1097/MPG.0000000000001375
Sheng W, Tang J, Cao R, Shi X, Ma Y, Dong M (2022) Numb-PRRL promotes TGF-β1- and EGF-induced epithelial-to-mesenchymal transition in pancreatic cancer. Cell Death Dis 13(2):173. https://doi.org/10.1038/s41419-022-04609-y
Sakata K, Eda S, Lee ES, Hara M, Imoto M, Kojima S (2014) Neovessel formation promotes liver fibrosis via providing latent transforming growth factor-β. Biochem Biophys Res Commun 443(3):950–956. https://doi.org/10.1016/j.bbrc.2013.12.074
Zhou Y, Jiang M, Tang ST et al (2017) Laparoscopic finding of a hepatic subcapsular spider-like telangiectasis sign in biliary atresia. World J Gastroenterol 23(39):7119–7128. https://doi.org/10.3748/wjg.v23.i39.7119
Xu M, Xu HH, Lin Y et al (2019) LECT2, a ligand for Tie1, plays a crucial role in liver fibrogenesis. Cell 178(6):1478-1492.e20. https://doi.org/10.1016/j.cell.2019.07.021
Qiu JL, Zhang GF, Chai YN et al (2022) Ligustrazine attenuates liver fibrosis by targeting miR-145 mediated transforming growth factor-β/Smad signaling in an animal model of biliary atresia. J Pharmacol Exp Ther 381(3):257–265. https://doi.org/10.1124/jpet.121.001020
Meng L, Liu J, Wang J et al (2021) Characteristics of the gut microbiome and IL-13/TGF-β1 mediated fibrosis in post-Kasai cholangitis of biliary atresia. Front Pediatr 9:751204. https://doi.org/10.3389/fped.2021.751204
Yang Y, Liu YJ, Tang ST et al (2013) Elevated Th17 cells accompanied by decreased regulatory T cells and cytokine environment in infants with biliary atresia. Pediatr Surg Int 29(12):1249–1260. https://doi.org/10.1007/s00383-013-3421-6
Vejchapipat P, Theamboonlers A, Poomsawat S, Chittmittrapap S, Poovorawan Y (2008) Serum transforming growth factor-beta1 and epidermal growth factor in biliary atresia. Eur J Pediatr Surg 18(6):415–418. https://doi.org/10.1055/s-2008-1038950
Ramm GA, Nair VG, Bridle KR, Shepherd RW, Crawford DH (1998) Contribution of hepatic parenchymal and nonparenchymal cells to hepatic fibrogenesis in biliary atresia. Am J Pathol 153(2):527–535. https://doi.org/10.1016/S0002-9440(10)65595-2
Lee SY, Chuang JH, Huang CC et al (2004) Identification of transforming growth factors actively transcribed during the progress of liver fibrosis in biliary atresia. J Pediatr Surg 39(5):702–708. https://doi.org/10.1016/j.jpedsurg.2004.01.030
Siyu P, Junxiang W, Qi W, Yimao Z, Shuguang J (2022) The role of GLI in the regulation of hepatic epithelial-mesenchymal transition in biliary atresia. Front Pediatr 10:861826. https://doi.org/10.3389/fped.2022.861826
Harada K, Sato Y, Ikeda H et al (2009) Epithelial-mesenchymal transition induced by biliary innate immunity contributes to the sclerosing cholangiopathy of biliary atresia. J Pathol 217(5):654–664. https://doi.org/10.1002/path.2488
Deng YH, Pu CL, Li YC et al (2011) Analysis of biliary epithelial-mesenchymal transition in portal tract fibrogenesis in biliary atresia. Dig Dis Sci 56(3):731–740. https://doi.org/10.1007/s10620-010-1347-6
Xiao Y, Zhou Y, Chen Y et al (2015) The expression of epithelial-mesenchymal transition-related proteins in biliary epithelial cells is associated with liver fibrosis in biliary atresia. Pediatr Res 77(2):310–315. https://doi.org/10.1038/pr.2014.181
Chu AS, Diaz R, Hui JJ et al (2011) Lineage tracing demonstrates no evidence of cholangiocyte epithelial-to-mesenchymal transition in murine models of hepatic fibrosis. Hepatology 53(5):1685–1695. https://doi.org/10.1002/hep.24206
Scholten D, Osterreicher CH, Scholten A et al (2010) Genetic labeling does not detect epithelial-to-mesenchymal transition of cholangiocytes in liver fibrosis in mice. Gastroenterology 139(3):987–998. https://doi.org/10.1053/j.gastro.2010.05.005
Taura K, Iwaisako K, Hatano E, Uemoto S (2016) Controversies over the epithelial-to-mesenchymal transition in liver fibrosis. J Clin Med 5(1):9. https://doi.org/10.3390/jcm5010009
Robertson H, Kirby JA, Yip WW, Jones DEJ, Burt AD (2007) Biliary epithelial-mesenchymal transition in posttransplantation recurrence of primary biliary cirrhosis. Hepatology 45(4):977–981. https://doi.org/10.1002/hep.21624
Acknowledgements
Funding by Tianjin Key Medical Discipline (Specialty) Construction Project, the Tianjin Science and Technology Program (No.21ZXGWSY00070) and the Tianjin Applied Basic Research Project (No.22JCZDJC00290).
Author information
Authors and Affiliations
Contributions
Conception and design: Jianghua Zhan, Shaowen Liu; administrative support: Jianghua Zhan; drawing of figures: Qianhui Yang; data extraction: Shaowen Liu, Yu Meng, Qianhui Yang; manuscript writing: all authors. All authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors have no competing interests to declare that are relevant to the content of this article.
Ethical approval
This is a systematic review. No ethical approval is required.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Zhan, J., Liu, S., Meng, Y. et al. Systematic review of the mechanism and assessment of liver fibrosis in biliary atresia. Pediatr Surg Int 40, 205 (2024). https://doi.org/10.1007/s00383-024-05778-x
Accepted:
Published:
DOI: https://doi.org/10.1007/s00383-024-05778-x